US FDA cites Bayer for Yaz TV commercial violations
This article was originally published in Scrip
Executive Summary
Two television commercials forBayer Healthcare's Yaz (drospirenone plus ethinylestradiol) broaden the oral contraceptive’s indication, overstate its efficacy and minimise risks, the US FDAhas said in a warning letter.